$6,214 for one cancer treatment prescription? In Part II of this two-part series, Marietta Armanyous compares Canadian and American prescription drug prices, exploring why U.S. pharmaceuticals are so much more expensive than those of any other developed nation.
America is cracking down on drug deals… even the good kind! In Part I of this two-part series, Marietta Armanyous looks at why the U.S. Senate voted against Bernie Sanders’ Drug Pricing Amendment, which would have allowed less expensive pharmaceuticals to be imported from Canada.
In an interview with Dr. Robert Teigrob from Ryerson University, Alexander Sawicki explores why the United States and Russia will not be friends for the foreseeable future – even with Trump in office.
The reversal occurred following the recent meetings and fundraisers with Chinese officials raises questions concerning Canada’s national security.
Slow economic growth is afflicting the industrialized world. One cause of the malaise is a steadily growing gap between rich and poor.
As Canada continues to prepare for leading a major NATO mission in Latvia. Here are 6 things you should know.
The cabinet shuffle gave Canada’s trade officials a new hand, but few new cards. Ross Linden-Fraser offers his take on what the changes can – and cannot – do for the country’s trade agenda.
Mary Zelenova explores President-elect Donald Trump’s stance on international affairs in order to analyze his potential foreign policy strategy. Find out what we might expect from the next President of the United States.
Will Trump’s words and Putin’s actions cause Europe to harden defences?
What is the US-Canada Joint Arctic Leaders’ Statement, and what are its provisions and effects? Mary Zelenova explores.